A blog covering the health/care ecosystem and people.

A couple of days into the U.S. Federal government shutdown, there’s one message the Congressional Democrats are tending to voice: that is that health care is on the line, and that’s the issue on which they’re betting will bring negotiators back to Capitol Hill — expecting a few Republicans to join in that dialogue. Most U.S. adults across political parties would want to see  Congress extend the enhanced Affordable Care Act tax credits that are set to expire next year we see in a poll from the Kaiser Family Foundation published October 3. And that includes most Republicans and MAGA

Welcome to Part 2 of 3 in my consideration of Prescription Drug Pricing in America. You can catch up with yesterday’s Part 1 post here, and Part 2 here. The macro-context for these 3 posts are the forecasts for health care spending for the coming year. Health care cost increases forecasted for 2026 will, in significant part, be driven by prescription drug trend. This graphic from this week’s release of the Business Group on Health’s employer survey on healthcare cost growth to 2026 illustrates a key finding that’s echoed in other similar studies recently released and covered here in Health Populi.

Health care costs will increase, overall, as much as 10% in 2026, the consensus of several health benefit analysts inform us. And, “workers to bear brunt of health cost increases in 2026,” reads today’s Axios headline on the topic, weaving together several studies from the Business Group on Health, Mercer, and the  International Foundation of Employee Benefit Plans.           A kay cost-contributor cited in all of these health cost forecasts is the prescription drug line item: specialty drug prices, and specifically the costs of GLP-1 medicines and cancer therapies. One strategy gaining fast-traction on both the

Among the top 20 fastest-growing growth brands beloved by Americans between 18 and 28 years of age — that is, Gen Z consumers — we see brand-equity love for companies channeling athleisure, fashion, new-fangled financial products, and food & beverage brands. And then there’s Ozempic, which gained 10 full percentage points from Q1-2025 to Q2-2025, according to The Harris Poll’s QuestBrand research. What does it mean that a prescription drug has joined these brand-loved rankings?                   The QuestBrand research found that as of the second quarter of 2025, more than one in 3

The pandemic era re-shaped consumers’ views on food as an input for health across all dimensions. We look back with affection for our local grocery stores and pharmacies which played leading roles as first responders f0r our health and, quite literally, the basic needs at the base of our personal hierarchies the way Maslow conceived them. As I tracked home-bound consumers’ behaviors from the start of COVID-19 in March 2020, I hunted-and-gathered data from Nielsen, Acosta, Circana, Gallup, Harris, and other sources of consumers @ retail. The DIY food-health concept, coined by Nielsen, was the build-up of our “pandemic pantries.”

For the third year in a row, medical cost trend — the expected increase of health care costs by health plans — will be 8.5% for group health insurance. This contrasts with a low of 5.5% in 2022 when cost trend dipped coming out of the COVID-19 pandemic….then shot up to 8.0% the following year in patients’ healthcare catch-up mode.                 Welcome to Behind the Numbers 2026, the annual medical trend report from PwC. What’s continuing to drive up health care costs? PwC identifies 4 medical cost inflators, and 2 “deflators” (these being

By 2033, national health spending will comprise 20.3% of the U.S. GDP, based on the latest national health expenditure projections developed by researchers from the Centers for Medicare and Medicaid Services (CMS). This growth will be happening as CMS projects coverage of insured people to decline over the period.               Earlier today, I attended a media briefing hosted by Health Affairs to receive the CMS team’s top-line forecast of NHE from 2024 to 2033 discussing these findings. Fuller details on the projections will be released in the July issue of Health Affairs on 7

There are many ways to measure the dysfunction of health care in the U.S.: we can point to relatively poor incomes relative to the rest of the developed world, given how much money is allocated to health care in America. The maternal mortality rate in the U.S. is unconscionably high, akin to some middle- and lower-income nations in the world. And medical debt is a uniquely American form of financial toxicity compared with other OECD nations where the concept is, well, foreign. Even with these many failures, though, it’s important to put U.S. health care in a larger context: the

Most people in the U.S. say it’s harder to eat healthy given the cost of “healthy food,” we learn in the report on Americans on Healthy Food and Eating from the Pew Research Center, published 7 May 2025. With a view that healthy food is “too expensive,” it may feel like aspiring for it feels like luxury-good shopping, or being a patient prescribed a specialty (high-cost) drug.               The Pew team polled 5,123 U.S. adults’ perspectives on eating, fielded between 24 February and 2 March 2025. This report is timely as Secretary of Health and

Americans’ financial health was already stressing consumers out leading up to Liberation Day, April 2nd, when President Trump announced tariffs on dozens of countries with whom the U.S. buys and sells goods. A new report from MoneyLion and Mastercard called Health is Wealth is well-timed for today’s Health Populi blog. The study was fielded by The Harris Poll online among 2,092 U.S. adults 18 and older between February 28 and March 4, 2025, so it was completed a month before the tariffs came to hit peoples’ 401(k) savings and employers’ company stock market caps.              

Art reflects life — or in this case, bumps into life and health care — once again when the pop culture facet of my own media consumption converges with a news announcement where the timing of these events is just too uncanny. It never occurred to me I’d ever write about the Hallmark Channel in the Health Populi blog. But reading the news that President Trump’s administration plans to cut funding for the ongoing 30-year study into diabetes and pre-diabetes — the landmark National Diabetes Prevention Program (NDPP) — dovetailed (or perhaps more honestly stated, collided) with the plotline of

The nature of retail pharmacy is changing, with both threats and opportunities re-shaping the business itself, and the pharmacy’s role in the larger health/care ecosystem. To keep sharp on the topics, I attended Rx Market Insights: Performance Trends and Outlook for 2025, a data-rich session presented on February 18 by IQVIA and sponsored by Ascend Laboratories. The webinar was hosted by DSN (Drug Store News), appropriately so because the action-packed hour went into detail providing the current state of prescription drugs and the pharmacy in America. Doug Long, IQVIA’s VP of Industry Relations, and Scott Biggs, the company’s Director of Supplier

Two polls from one poll source paint at once a bipartisan and bipolar picture of U.S. health citizens when it comes to health care issues versus health care institutions in America. The Kaiser Family Foundation has hit the 2025 health policy ground running in publishing the January 2025 Health Tracking Poll last week and a poll on health care trust and mis-information yesterday.                        First, the health tracking poll which finds some concurrence between Democrats and Republicans on several big issues facing Americans and various aspects of their health care. As

There were over 4,500 exhibitors on the show floor of the 2025 CES in Las Vegas last week, addressing every imaginable aspect of consumers’ daily lives as we increasingly coexist with technology to support life, liberty, and our personal pursuits of happiness….. ….and health. My focus is always on health, and in the past decade and a half, health/care, everywhere. So my lens on #CES2025 looked out for specific point solutions for health, medical care, fitness and well-being, along with adjacencies for mobility/auto, environmental health (think: clean air, clean water), kitchen appliances and food-tech, and home care (not the medical

At this year-end time each year, my gift to Health Populi readers is an annual “TrendCast,” weaving together key data and stories at the convergence of people, health care, and technology with a look into the next 1-3 years. If you don’t know my work and “me,” my lens is through health economics broadly defined: I use a slash mark between “health” and “care” because of this orientation, which goes well beyond traditional measurement of how health care spending is included in a nation’s gross domestic product (GDP); I consider health across the many dimensions important to people, addressing physical,

Americans’ perception of the quality of health care in the U.S. fell to the lowest level since 2001, Gallup found in a poll of U.S. health citizens’ views on health care quality, published December 6, 2024.              In 2024, only 44% of Americans said that the quality of health care int he U.S. was excellent or good — conversely, 56% of Americans though health care quality was only fair or poor. By political party, that included 50% of Democrats evaluating the quality of care highly compared with 42% of Republicans. Only 28% of people in

Patients “yearn” for personalized services and relationships in health care — optimistic that technology can help deliver on that hope — we learn in Healthcare’s Future: Balancing Progress and Perception, a health consumer survey report from Lavidge. Lavidge, a communications/PR/marketing consultancy, polled U.S. patients’ attitudes about health care and technology in June 2024, publishing the report earlier this month.                   Start with over-arching finding that, “Three out of four patients believe the U.S. healthcare system is broken and there is a strong sense of distrust,” Lavidge asserts right at the top of

The premium for employer-sponsored health plans grew by 6-7% between 2023 and 2024, according to the report on Employer Health Benefits 2024 Annual Survey from the Kaiser Family Foundation, KFF’s 26th annual study into U.S. companies’ spending on workers’ health care.                 In 2024 the average annual health insurance premium for family coverage is $25,572, split by 75% covered by the employer (just over $19,000) and 25% borne by the employee ($6,296), shown in the first chart from the report. The nearly $26K family premium is the average across all plan types in the

“If the U.S. were sensible, weight management would be treated as a public health issue,” David Cutler writes in the JAMA Health Forum dated August 15, 2024. Dr. Cutler, distinguished economics professor at Harvard, talks about “the pathology of U.S. health care” citing the example of weight loss medications — in short, the uptake of GLP-1 drugs to address Type 2 diabetes first, and subsequently obesity.          Dr. Cutler notes that the price of these drugs in the U.S. “far exceeds” that of other countries: specifically, 9 times that of the prices in Germany and the Netherlands

Women in the U.S. have lower life expectancy, greater risks of heart disease, and more likely to face medical bills and self-rationing due to costs, we learn in the latest look into Health Care for Women: How the U.S. Compares Internationally from The Commonwealth Fund.              The Fund identified four key conclusions in this global study: Mortality, shown in the first chart which illustrates women in the U.S. having the lowest life expectancy of 80 years versus women in other high-income countries; Health status, with women in the U.S. more likely to consume multiple prescription

The U.S. Bureau of Labor Statistics had good news for American consumers long-facing inflation for household spending over the past couple of years, announcing on July 11, 2024, that the general consumer price index (CPI) fell, lowering real prices for people buying airline tickets, used cars and trucks, communication, and petrol to fill auto tanks.               That positive economic news did not extend to medical care and personal care, the BLS reported, whose costs increased by 3.3% and 3.2%, respectively. (Motor vehicle insurance costs grew a whopping 19.5% in the report, FYI). Following the

From bandages to home hygiene, OTC pain meds and DIY home projects, Morning Consult’s look into the most-trusted brands of 2024 give us insights into health consumers. I’ve been tracking this study since before the public health crisis of the coronavirus, and it always offers us a practical snapshot of the U.S. consumer’s current ethos on trusted companies helping people risk-manage daily living — and of course, find joy and satisfaction as well. In the top 15, we find self-care for health and well-being in many brands and products: we can call out Band-Aid, Dove, Colgate, Kleenex, and Tylenol. For

Health insurance plans make mainstream media news every week, whether coverage deals with the cost of a plan, the cost of out-of-network care, prior authorizations, or cybersecurity and ransomware attacks, among other front-page issues. This week, AHIP (the acronym for the industry association of America’s Health Insurance Plans) is convening in Las Vegas for its largest annual 2024 meeting. We expect at least 2,400 attendees registered for the meeting, and they’ll not just be representing the health insurance industry itself; folks will attend #AHIP2024 from other industry segments including pharmaceuticals, technology, hospitals and health systems, and the investment and financial services

In the past year, the growth of prescription drug utilization and spending has much to do with the use of GLP-1 agonists to treat diabetes and obesity, along with immunology therapy, and lipid meds, along with specialty medicines now accounting for over half of spending — up from 49% in 2018. This update comes from The Use of Medicines in the U.S. 2024 from the IQVIA Institute for Human Data Science. The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028.

Among Americans 50 years of age and over, the top health-related concerns are Cost, Cost, and Cost — for medical services, for long-term and home care, and for prescription medications. Quality of care ranks lower as a concern versus the financial aspects of health care in America among people 50 years of age and older, as we learn what’s On Their Minds: Older Adults’ Top Health-Related Concerns from the University of Michigan Institute for Healthcare Policy and Innovation. AARP sponsors this study, which is published nearly every month of the year on the Michigan Medicine portal.           

Three major milestones marked March 2024 which compel us to note the growing role of patients-as-consumers — especially for self-prescribing medicines and medical devices. This wave of self-prescribed healthcare is characterized by three innovations: the Opill, GLP-1 receptor agonists, and Dexcom’s Continuous Glucose Monitoring (CGM) system that’s now available without a prescription. Together, these products reflect a shift in health care empowerment toward patients as consumers with greater autonomy over their health care when the products and services are accessible, affordable, and designed with the end-user central to the value proposition and care flows. Let’s take a look at each

At the end of each year since I launched the Health Populi blog, I have put my best forecasting hat on to focus on the next year in health and health care. For this round, I’m firmly focused on the key noun in health care, which is the patient – as consumer, as Chief Health Officer of the family, as caregiver, as health citizen. As my brain does when mashing up dozens of data points for a “trendcast” such as this, I’ll start with big picture/macro on the economy to the microeconomics of health care in the family and household,

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” the CEO of Walmart US is quoted in Bloomberg. “Just less units, slightly less calories.”                   With patients’ use  GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro fast-rising in the pharmacy market, so are the concerns of companies that stock the-middle-of-the-grocery-store aisles for processed foods like sweet and salty snacks. As the prospects for the drug companies who manufacture prescription drugs made for patients managing diabetes and obesity are on the

The retail health landscape continues to grow, now with GNC Health offering a new program featuring telehealth and  “curated set” of 40+ generic prescription drugs commonly used in urgent care settings.             The services are available to members of GNC’s new-and-improved loyalty program, GNC PRO Access, which is priced at a fixed fee of $39.99 for one year’s membership. This is available to consumers 18 years of age and older. “As a trusted brand in the health and wellness space, we are thrilled to expand our efforts in helping our customers Live Well by offering

You may not be able to get that ear-worm jingle that goes “O O O Ozempic” out of your musical mind, but I’m happy to tell you there’s a new “O” in town: the Opill. Welcome to the first OTC contraceptive for sale in the USA.                     I wrote about Perrigo’s Opill here in Health Populi in May 2023 as a “signpost on the road to retail health.” It’s official: “The U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages.

In health care, one of the “gifts” inspired by the coronavirus pandemic was the industry’s fast-pivot and adoption of digital health tools — especially telehealth and more generally the so-called “digital front doors” enabling patients to access medical services and personal work-flows for their care. Two years later, Experian provides a look into The State of Patient Access: 2023.                     You may know the name Experian as one of the largest credit rating agencies for consumer finance in the U.S. You may not know that the company has a significant footprint

We continue to track to evolving, expanding landscape of retail health — which we see as the expanding ecosystem of health/care accessible to people-as-health consumers. This week, three intriguing examples are resonating with us: The ever-evolving weight-loss industry FDA favors OTC use for Perrigo’s Opill daily oral contraceptive birth control pill The convergence of fashion and health — specifically, how an over-the-counter medicine converges with clothing that helps us feel better.                   Let’s start with weight-loss, as several aspects of health/care come together in the consumer’s retail health sandbox. Dr. Eric Topol

The COVID-19 pandemic re-shaped European Union leaders to reimagine healthcare, public health, and health citizenship in the EU. Welcome to #HealthUnion, the hashtag that the European Commission has adopted with the vision of assuring access to medicines for all people living in the 27-nation EU area — regardless of socioeconomic status.             On 26th April 2023, the EC unveiled the most significant reforms for the region’s pharmaceutical industry in twenty years. It’s really a package or “toolkit” in the words of EC Health and Food Safety Commissioner Stella Kyriakides for addressing several strategic health pillars

“Are we losing the battle against heart disease?” asks the lead article featured in the January 2023 issue of the AARP Bulletin.           “Despite breathtaking medical advancements since President Harry Truman declared war on heart disease 75 years ago, researchers have observed a disturbing trend that started in 2009: America’s death rate from heart-related conditions is climbing again,” the detailed essay explains. AARP is in fact a very visible stakeholder in the 2023 CES, collaborating on the AgeTech content track at the tech conference. The track covers all aspects of aging well, from financial health to entertainment,

Health is “made” where we live, work, play, pray, learn….and shop. I spend a lot of time these days in the growing health/care ecosystem where retail health is broadening to address social determinants and drivers of health – namely food, transportation, broadband access, education, environment, and financial wellness – all opportunities for self-care and health engagement. For many years, I have followed the activities of CHPA, the Consumer Healthcare Products Association, and have participated in some of their conferences. Their recent announcement of a collaboration with Dollar General speaks to the growing role of self-care for all people.    

Patients have more financial skin-in-their-healthcare-games facing high-deductibles and direct out-of-pocket costs for medical bills…including prescription drugs. I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer, with implications and calls-to-action for pharma and life science companies. You can download the paper at this link.               The report is intended to be a playbook for understanding patients’ growing role as consumers and health care payers, providing insights into peoples’ home economic mindsets and how these impact a patient’s adherence to medication based on cost and perceived value. With inflation facing household

Thinking about the social determinants of prescription drugs, how people take medicines in real life in my latest post in Medecision’s Liberate Health blog.           I had one of those special lightbulb moments when listening to Mauricio Gonzalez-Arias, M.D. of NYC Health + Hospitals and Suvida Healthcare discussing medication adherence and what prevents us from taking our meds as prescribed. His discussion on social determinants’ role in shaping our relationship with prescriptions was powerful, and the jumping off point for this essay.           Medication adherence is a challenge that fiscally costs the

The goal of self-care for health-making is to improve lives by scaling health-and-wellness accessible to all, Bayer believes, giving people more control over their personal health. Self-care work-flows must be based in science to ensure products and services are trusted and deliver on their clinical promise, Bayer explains in Science-Led Self-Care: Principles for Best Practice, a paper published this week which the company intends to be a blueprint for the industry.                 Bayer recognizes that self-care is growing among health consumers around the world — albeit underpinned by peoples’ cultures, demographics, and “readiness”

The good news about prescription drugs, in the context of medical spending in the U.S., is that 9 in 10 medicines prescribed are generics. They comprise only 3% of all U.S. healthcare spending.           But there’s bad news about prescription drugs in the context of medical spending in America. U.S. Consumers Overpay for Generic Drugs, a new paper from the Leonard Schaeffer Center for Health Policy & Economics asserts, with recommendations to address the intermediaries who benefit from the way Americans currently pay for medicines. Generics are “an American success story,” the authors call out, bringing

The COVID-19 pandemic has impacted patients who were already deeply engaged with their own health care before the coronavirus emerged. Compared with a year ago, more patients and their advocates are seeking quality therapies, innovation, engagement, and integrity from pharmaceutical companies, based on research published today from PatientView. PatientView, based in the UK, has collaborated with over 40,000 patient advocacy organizations globally marking over 10 years doing this research. The eleventh annual report on the Corporate Reputation of Pharma was conducted among 2,150 patient groups between November 2021 and February 2022, covering health citizens in Europe (with 1,229 organizations), North

Two pharmaceutical companies bubble up among the 20 fastest-growing brands for 2021 in Morning Consult’s report on the Fastest-Growing Brands of 2021. But the surprise in this year’s top 20 brand rankings was that five of them addressed consumers’ financial flows: Coinbase, AfterPay. Cash App, Mastercard, Chime, and Bitcoin. One year ago when I covered this study, I found  that the fastest-growing brands of 2020 had everything to do with the pandemic. They dealt with home entertainment, digital connectivity, hygiene, and indeed, health (with Pfizer and AstraZeneca the two pharma brands top-of-mind for consumers). In this year’s update, exploring consumers’

A new look into Americans’ views on health privacy from Morning Consult provides a current snapshot on citizens’ concerned embrace of technology — worried pragmatism, let’s call it. This ambivalence will flavor how health citizens will adopt and adapt to the growing digitization of health care, and challenge the healthcare ecosystem’s assumption that patients and caregivers will universally, uniformly engage with medical tools and apps and technologies. More Boomers are concerned with health data app privacy than Gen Z consumers, as the chart illustrates. 46% of U.S. adults said that health monitoring apps were not an invasion of privacy; 32%

In April 2020, telemedicine morphed into mainstream medical care as hospitals and physicians risk-managed exposure to infection by meeting with patients, virtually, when possible. By March 2020, telehealth channels were replacing visits to doctors and emergency departments as shown in the first chart from the CDC’s report on the early pandemic period. By the spring of 2021, telehealth use stabilized, but health systems had built the processes and policies to deliver on the promise of omni-channel health care — from the patient’s home and hands (via smartphones) into community sites closer-to-home, and returning to brick-and-mortar medical buildings. Welcome to Telehealth

“You can trust us to help you find the right Medicare coverage for you and your lifestyle,” the tagline reads. What kind of organization would be behind this campaign: a healthcare navigator company, an insurance company, or a social services agency? In fact, it’s a grocery store called Hy-Vee, which launched the “Medicare Aisle” to help consumers living in the eight states in which the chain’s 240+ stores operate to sort through the daunting labyrinth of Medicare choices. “Hy-Vee is a trusted leader in the health and wellness space, and as a retail and specialty pharmacy provider, we are deeply

When we say the word “pharmacy,” we might picture the Main Street brick-and-mortar chain drugstore that dispenses medicines from behind the counter in the far back of the building, and sweet and salty snacks at the front by the cashier. In fact, “pharmacy” is the jumping off point for the expanding and increasingly beloved retail health ecosystem, J.D. Power found in the company’s latest 2021 U.S. Pharmacy Study. Each year, J.D. Power assesses consumers’ perceptions of pharmacies by category, including those retail chains along with supermarket operated, mass merchants, and mail order channels. This is the 13th year of the

“Self-care” took on new meaning and personal work-flows for people living in and through the coronavirus pandemic in the U.S. Acosta, the retail market research pro’s, updated our understanding consumers evolving as COVID-19 Has Elevated the Health and Wellness Trends of the Recent Years, results of a survey conducted among in May 2021. In the U.S., consumers’ take on self-care has most to do with healthy eating and nutrition (for 1 in 2 people), getting regular medical checkups (for 42%), taking exercise, relaxing, using vitamins and supplements, and getting good sleep. Healthy relationships are an integral part of self-care for

Getting totally rid of the coronavirus isn’t likely, so we humans must accept the fact that SARS-CoV-2 will be endemic. The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape, delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. I welcomed the opportunity to learn from this team’s approach in weaving together the dynamic issues that help us to plan for the long-tail of COVID-19 and its impact on the economy and prospects for the health care industry and health citizens. The first graph illustrates the

The emergence of the COVID-19 vaccine “infodemic” has slowed the ability for nations around the world to emerge out of the public health crisis. Growing cynicism among some health citizens facing the politicization of public health tactics like vaccines and facial masks is what we’re talking about. At the root is peoples’ lack of trust across a range of information providers, including government, media, business, and even peers. The 2021 Edelman Trust Barometer spotlighted the infodemic and eroding trust in the U.S. in the voices of public health, the public sector, and media. This is a global challenge as well,

Spending on medicines, globally, will rebound this year and rise above pre-pandemic levels through 2025. Between 2021 and 2025, the annual growth global growth rate for prescription drugs spending is expected to range from 3% to 6%, a $1.6 trillion bill for the worlds’s total Rx medicines market. That relatively low single-digit growth rate is tempered by savings from biosimilars and the loss of brand exclusivity (that is, more generics coming to market). On the faster-growth side, we can expect two big therapeutic areas to drive spending upward: oncology and immunology, projected to expand by 9% to 12% each year